In this first limb of the PROACT , patients with elevated risk factors for thromboembolism were randomized at @ US centers to receive lower dose warfarin ( test international normalized ratio -LSB- INR -RSB- , @-@ @ ) or continue standard warfarin ( control INR , @-@ @ ) , @ months after mechanical aortic valve replacement .